US Stock MarketDetailed Quotes

CASI Pharmaceuticals (CASI)

Watchlist
  • 0.970
  • -0.070-6.73%
Trading Jan 16 12:55 ET
19.93MMarket Cap-0.32P/E (TTM)

CASI Pharmaceuticals (CASI) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Total revenue
-60.54%3.08M
4.93%4.18M
83.04%6.24M
-15.77%28.54M
94.30%13.36M
-11.82%7.79M
-59.48%3.98M
-59.16%3.41M
-21.41%33.88M
-54.95%6.87M
Operating revenue
-60.54%3.08M
4.93%4.18M
83.04%6.24M
-15.77%28.54M
94.30%13.36M
-11.82%7.79M
-59.48%3.98M
-59.16%3.41M
-21.30%33.88M
-54.95%6.87M
Cost of revenue
-36.79%2.37M
10.72%2.12M
63.51%2.62M
25.78%17.39M
259.79%10.13M
2.74%3.75M
-52.03%1.91M
-52.55%1.6M
-12.64%13.83M
-34.11%2.82M
Gross profit
-82.55%706K
-0.44%2.06M
100.39%3.62M
-44.41%11.15M
-20.47%3.23M
-22.06%4.05M
-64.57%2.07M
-63.65%1.81M
-26.50%20.05M
-63.06%4.06M
Operating expense
-9.73%10.95M
9.87%12.77M
25.64%13.85M
11.09%50.36M
76.59%15.58M
16.21%12.13M
-23.22%11.62M
-9.93%11.03M
-15.69%45.33M
-45.15%8.82M
Selling and administrative expenses
-10.10%9.54M
6.53%11.04M
39.44%11.92M
-0.94%41.44M
3.01%11.92M
31.97%10.61M
-17.20%10.37M
-11.93%8.55M
10.75%41.84M
-2.28%11.57M
-Selling and marketing expense
-6.07%4.61M
12.09%4.96M
13.04%4.22M
8.61%17.87M
-6.85%4.8M
94.92%4.91M
-8.20%4.43M
-5.70%3.74M
14.83%16.45M
26.07%5.15M
-General and administrative expense
-13.58%4.93M
2.39%6.08M
59.94%7.7M
-7.13%23.58M
10.92%7.12M
3.26%5.7M
-22.84%5.94M
-16.22%4.81M
8.26%25.39M
-17.21%6.42M
Research and development costs
-7.10%1.41M
37.48%1.72M
-21.81%1.94M
-9.57%8.92M
58.43%3.67M
-36.60%1.52M
-52.03%1.25M
-2.29%2.48M
-38.35%9.86M
-45.53%2.31M
Other operating expenses
----
----
---5K
99.97%-2K
----
----
----
----
---6.37M
---5.06M
Operating profit
-26.70%-10.24M
-12.10%-10.71M
-11.00%-10.23M
-55.11%-39.21M
-159.27%-12.35M
-54.06%-8.09M
-2.72%-9.55M
-26.77%-9.22M
4.57%-25.28M
6.59%-4.77M
Net non-operating interest income expense
-203.28%-185K
-261.82%-199K
-96.72%-120K
-154.07%-332K
-238.39%-155K
-137.89%-61K
-139.57%-55K
-130.20%-61K
383.46%614K
330.77%112K
Non-operating interest income
-93.01%10K
-66.67%45K
-41.22%77K
-14.31%539K
--130K
--143K
--135K
--131K
232.80%629K
----
Non-operating interest expense
-4.41%195K
28.42%244K
2.60%197K
5,706.67%871K
--285K
--204K
--190K
--192K
-75.81%15K
----
Total other finance cost
----
----
----
----
----
137.89%61K
139.57%55K
130.20%61K
----
----
Other net income (expense)
-152.36%-454K
-111.04%-292K
-60.08%-397K
190.71%1.48M
-44.31%-1.79M
36.32%867K
371.74%2.64M
-119.75%-248K
85.31%-1.63M
89.17%-1.24M
Gain on sale of security
-152.06%-454K
-114.30%-304K
-2.22%-415K
494.75%1.5M
-309.63%-1.09M
434.97%872K
316.50%2.13M
-401.23%-406K
93.26%-381K
108.70%519K
Earnings from equity interest
----
----
----
--0
----
----
----
----
--0
----
Special income (charges)
--0
--0
----
89.20%-217K
64.31%-717K
--0
--500K
----
81.37%-2.01M
---2.01M
-Less:Impairment of capital assets
----
----
----
--696K
----
----
----
----
--0
----
-Write off
----
----
----
--0
----
----
----
----
--2.01M
----
-Gain on sale of property,plant,equipment
--0
--0
----
--479K
---21K
--0
--500K
----
--0
--0
Other non- operating income (expenses)
----
-33.33%12K
-88.61%18K
-75.39%188K
-93.23%17K
-101.06%-5K
100.00%18K
-88.18%158K
1,636.36%764K
1,668.75%251K
Income before tax
-49.51%-10.88M
-60.82%-11.2M
-12.83%-10.75M
-44.79%-38.07M
-142.65%-14.3M
-63.54%-7.28M
31.28%-6.97M
-63.88%-9.53M
29.76%-26.29M
64.32%-5.89M
Income tax
0
0
0
0
0
0
0
0
-104.09%-81K
-100.05%-1K
Earnings from equity interest net of tax
--0
---2.17M
--0
-2,377.08%-1.19M
-7,200.00%-73K
-7,340.00%-1.12M
--0
--0
94.33%-48K
99.88%-1K
Net income
-29.64%-10.88M
-92.03%-13.38M
-12.83%-10.75M
-49.50%-39.26M
-143.89%-14.37M
-87.98%-8.4M
30.83%-6.97M
-63.40%-9.53M
34.77%-26.26M
69.54%-5.89M
Net income continuous Operations
-29.64%-10.88M
-92.03%-13.38M
-12.83%-10.75M
-49.50%-39.26M
-143.89%-14.37M
-87.98%-8.4M
30.83%-6.97M
-63.40%-9.53M
34.77%-26.26M
69.54%-5.89M
Minority interest income
0
0
0
0
0
-10.30%679K
-16.84%163K
Net income attributable to the parent company
-29.64%-10.88M
-92.03%-13.38M
-12.83%-10.75M
-45.73%-39.26M
-137.32%-14.37M
-81.12%-8.4M
31.98%-6.97M
-58.56%-9.53M
34.32%-26.94M
69.01%-6.06M
Preferred stock dividends
22K
Other preferred stock dividends
Net income attributable to common stockholders
-29.64%-10.88M
-92.03%-13.38M
-12.83%-10.75M
-45.62%-39.26M
-136.47%-14.37M
-81.12%-8.4M
31.98%-6.97M
-58.56%-9.53M
34.27%-26.96M
68.89%-6.08M
Basic earnings per share
-21.82%-0.67
-65.38%-0.86
2.82%-0.69
-26.73%-2.56
-71.74%-0.79
-57.14%-0.55
32.47%-0.52
-57.78%-0.71
32.89%-2.02
68.06%-0.46
Diluted earnings per share
-21.82%-0.67
-65.38%-0.86
2.82%-0.69
-26.73%-2.56
-71.74%-0.79
-57.14%-0.55
32.47%-0.52
-57.78%-0.71
32.89%-2.02
68.06%-0.46
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Total revenue -60.54%3.08M4.93%4.18M83.04%6.24M-15.77%28.54M94.30%13.36M-11.82%7.79M-59.48%3.98M-59.16%3.41M-21.41%33.88M-54.95%6.87M
Operating revenue -60.54%3.08M4.93%4.18M83.04%6.24M-15.77%28.54M94.30%13.36M-11.82%7.79M-59.48%3.98M-59.16%3.41M-21.30%33.88M-54.95%6.87M
Cost of revenue -36.79%2.37M10.72%2.12M63.51%2.62M25.78%17.39M259.79%10.13M2.74%3.75M-52.03%1.91M-52.55%1.6M-12.64%13.83M-34.11%2.82M
Gross profit -82.55%706K-0.44%2.06M100.39%3.62M-44.41%11.15M-20.47%3.23M-22.06%4.05M-64.57%2.07M-63.65%1.81M-26.50%20.05M-63.06%4.06M
Operating expense -9.73%10.95M9.87%12.77M25.64%13.85M11.09%50.36M76.59%15.58M16.21%12.13M-23.22%11.62M-9.93%11.03M-15.69%45.33M-45.15%8.82M
Selling and administrative expenses -10.10%9.54M6.53%11.04M39.44%11.92M-0.94%41.44M3.01%11.92M31.97%10.61M-17.20%10.37M-11.93%8.55M10.75%41.84M-2.28%11.57M
-Selling and marketing expense -6.07%4.61M12.09%4.96M13.04%4.22M8.61%17.87M-6.85%4.8M94.92%4.91M-8.20%4.43M-5.70%3.74M14.83%16.45M26.07%5.15M
-General and administrative expense -13.58%4.93M2.39%6.08M59.94%7.7M-7.13%23.58M10.92%7.12M3.26%5.7M-22.84%5.94M-16.22%4.81M8.26%25.39M-17.21%6.42M
Research and development costs -7.10%1.41M37.48%1.72M-21.81%1.94M-9.57%8.92M58.43%3.67M-36.60%1.52M-52.03%1.25M-2.29%2.48M-38.35%9.86M-45.53%2.31M
Other operating expenses -----------5K99.97%-2K-------------------6.37M---5.06M
Operating profit -26.70%-10.24M-12.10%-10.71M-11.00%-10.23M-55.11%-39.21M-159.27%-12.35M-54.06%-8.09M-2.72%-9.55M-26.77%-9.22M4.57%-25.28M6.59%-4.77M
Net non-operating interest income expense -203.28%-185K-261.82%-199K-96.72%-120K-154.07%-332K-238.39%-155K-137.89%-61K-139.57%-55K-130.20%-61K383.46%614K330.77%112K
Non-operating interest income -93.01%10K-66.67%45K-41.22%77K-14.31%539K--130K--143K--135K--131K232.80%629K----
Non-operating interest expense -4.41%195K28.42%244K2.60%197K5,706.67%871K--285K--204K--190K--192K-75.81%15K----
Total other finance cost --------------------137.89%61K139.57%55K130.20%61K--------
Other net income (expense) -152.36%-454K-111.04%-292K-60.08%-397K190.71%1.48M-44.31%-1.79M36.32%867K371.74%2.64M-119.75%-248K85.31%-1.63M89.17%-1.24M
Gain on sale of security -152.06%-454K-114.30%-304K-2.22%-415K494.75%1.5M-309.63%-1.09M434.97%872K316.50%2.13M-401.23%-406K93.26%-381K108.70%519K
Earnings from equity interest --------------0------------------0----
Special income (charges) --0--0----89.20%-217K64.31%-717K--0--500K----81.37%-2.01M---2.01M
-Less:Impairment of capital assets --------------696K------------------0----
-Write off --------------0------------------2.01M----
-Gain on sale of property,plant,equipment --0--0------479K---21K--0--500K------0--0
Other non- operating income (expenses) -----33.33%12K-88.61%18K-75.39%188K-93.23%17K-101.06%-5K100.00%18K-88.18%158K1,636.36%764K1,668.75%251K
Income before tax -49.51%-10.88M-60.82%-11.2M-12.83%-10.75M-44.79%-38.07M-142.65%-14.3M-63.54%-7.28M31.28%-6.97M-63.88%-9.53M29.76%-26.29M64.32%-5.89M
Income tax 00000000-104.09%-81K-100.05%-1K
Earnings from equity interest net of tax --0---2.17M--0-2,377.08%-1.19M-7,200.00%-73K-7,340.00%-1.12M--0--094.33%-48K99.88%-1K
Net income -29.64%-10.88M-92.03%-13.38M-12.83%-10.75M-49.50%-39.26M-143.89%-14.37M-87.98%-8.4M30.83%-6.97M-63.40%-9.53M34.77%-26.26M69.54%-5.89M
Net income continuous Operations -29.64%-10.88M-92.03%-13.38M-12.83%-10.75M-49.50%-39.26M-143.89%-14.37M-87.98%-8.4M30.83%-6.97M-63.40%-9.53M34.77%-26.26M69.54%-5.89M
Minority interest income 00000-10.30%679K-16.84%163K
Net income attributable to the parent company -29.64%-10.88M-92.03%-13.38M-12.83%-10.75M-45.73%-39.26M-137.32%-14.37M-81.12%-8.4M31.98%-6.97M-58.56%-9.53M34.32%-26.94M69.01%-6.06M
Preferred stock dividends 22K
Other preferred stock dividends
Net income attributable to common stockholders -29.64%-10.88M-92.03%-13.38M-12.83%-10.75M-45.62%-39.26M-136.47%-14.37M-81.12%-8.4M31.98%-6.97M-58.56%-9.53M34.27%-26.96M68.89%-6.08M
Basic earnings per share -21.82%-0.67-65.38%-0.862.82%-0.69-26.73%-2.56-71.74%-0.79-57.14%-0.5532.47%-0.52-57.78%-0.7132.89%-2.0268.06%-0.46
Diluted earnings per share -21.82%-0.67-65.38%-0.862.82%-0.69-26.73%-2.56-71.74%-0.79-57.14%-0.5532.47%-0.52-57.78%-0.7132.89%-2.0268.06%-0.46
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion--
Market Insights
Nancy Pelosi Portfolio
China Concept Stocks
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More